Medical Equipment

The Rise Of Innovations in Drug-Coated Balloon Technology Is Influencing The Drug-Coated Balloons Market

April 10, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Drug-Coated Balloons Market During The Forecast Period?

The drug-coated balloons market has experienced substantial growth in recent years. It is projected to expand from $1.24 billion in 2025 to $1.43 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.5%. Historically, this expansion can be attributed to factors including the rising prevalence of cardiovascular diseases, an increase in interventional cardiology procedures, the early adoption of paclitaxel-coated balloons, a growing need for restenosis prevention, and continued advancements in angioplasty techniques.

The market size for drug-coated balloons is projected to experience substantial expansion in the coming years. By 2030, it is anticipated to reach $2.55 billion, demonstrating a compound annual growth rate (CAGR) of 15.6%. This projected growth during the forecast period stems from factors such as the increasing utilization of dcb therapies in coronary applications, the rising adoption of next-generation coating technologies, the expansion of catheter-based interventions, growing investments in vascular innovation, and a heightened preference for stent-free treatment options. Significant trends anticipated during this period include the wider uptake of sirolimus-coated balloons, the increased use of dcbs in peripheral artery disease, a growing inclination towards minimally invasive vascular treatments, the advancement of sophisticated drug-coating technologies, and a stronger focus on enhancing drug delivery efficiency.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10829&type=smp

Which Key Drivers Are Affecting The Drug-Coated Balloons Market Development?

The expanding quantity of ambulatory surgery centers is projected to drive the progression of the drug-coated balloon market in the future. An Ambulatory Surgical Center (ASC) refers to a healthcare institution focused on conducting surgical operations that do not necessitate an overnight hospital admission. Within ambulatory surgery centers (ASC), drug-coated balloons hold significant importance, generally providing quicker procedure durations compared to standard balloons, which results in improved patient flow and reduced operational expenditures for ASCs. For example, as reported by the Medicare Payment Advisory Commission (an independent U.S. federal advisory agency) in March 2025, the count of Medicare-certified ASCs increased by 2.5% from 2022 to 2023, reaching 6,308 ASCs, indicating a net addition of 155 facilities over 2023. Consequently, the increasing prevalence of ambulatory surgery centers is propelling the expansion of the drug-coated balloon market.

How Are Different Segments Classified In The Drug-Coated Balloons Market Segment Analysis?

The drug-coated balloons market covered in this report is segmented –

1) By Product: Drug-Coated Balloons For Peripheral Artery Disease, Drug-Coated Balloons For Coronary Artery Disease

2) By Drug Type: Paclitaxel, Sirolimus

3) By End User: Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers

Subsegments:

1) By Drug-Coated Balloons For Peripheral Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

2) By Drug-Coated Balloons For Coronary Artery Disease: Paclitaxel-Coated Balloons, Sirolimus-Coated Balloons

What Trends Are Transforming The Drug-Coated Balloons Market?

Companies operating in the drug-coated balloons sector are primarily focused on enhancing their technological innovations, particularly with advancements like paclitaxel-coated balloon catheters. The goal is to improve treatment effectiveness for ailments such as coronary in-stent restenosis, ultimately leading to better patient outcomes and a reduction in potential complications linked to traditional therapies. Paclitaxel-coated balloon catheters are specialized devices that release the drug paclitaxel into the arterial wall when expanded, working to prevent the re-narrowing of arteries after an angioplasty procedure. As an illustration, in March 2024, Boston Scientific Corporation, a medical device company based in the US, received approval from the US Food and Drug Administration (FDA) for its AGENTTM Drug-Coated Balloon (DCB). This particular device is designed to treat coronary in-stent restenosis (ISR) in patients diagnosed with coronary artery disease, a condition where a previously stented blood vessel becomes blocked or narrowed by plaque or scar tissue.

Who Are The Companies Driving Activity In The Drug-Coated Balloons Market?

Major companies operating in the drug-coated balloons market are Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, B. Braun Melsungen AG, Terumo Corporation, Biotronik SE & Co. KG, Biosensors International Group Ltd, Concept Medical Inc., Acotec Scientific AG, Cardionovum GmbH, MedAlliance SA, iVascular SLU, Minvasys SAS, QT Vascular Ltd, Hexacath SAS, Cordis Corporation, MicroPort Scientific Corporation, Endocor GmbH, Orchestra BioMed Inc., Lepu Medical Technology Co. Ltd, Balton Sp. z o.o., BrosMed Medical Co. Ltd

Get The Full Drug-Coated Balloons Market Report:

https://www.thebusinessresearchcompany.com/report/drug-coated-balloons-global-market-report

Which Region Is The Largest In The Drug-Coated Balloons Market?

North America was the largest region in the global drug-coated balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-coated balloons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug-Coated Balloons Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=10829&type=smp

Browse Through More Reports Similar to the Global Drug-Coated Balloons Market 2026, By The Business Research Company

Drug Eluting Balloons Catheters Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Intragastric Balloons Market Report 2026

https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Angioplasty Balloons Market Report 2026

https://www.thebusinessresearchcompany.com/report/angioplasty-balloons-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795